In this study, probable antinociceptive and anti-inflammatory effects of El
aeagnus angustifolia fruit components, were evaluated. For evaluation of an
tinociceptive effects, the chronic (formalin test) and acute (tail-flick) p
ain models of rats were used. For the anti-inflammatory effects, the paw in
flammation model was used through subcutaneous injection of 5% formalin to
the paw of male rats. Water extracts of the fruit and its components in the
single dose were assessed through comparison with the antinociceptive and
anti-inflammatory effects of sodium salicylate (SS) as a positive control.
Administration of 300 mg/kg of SS (i.p.) had no effect on tail flick latenc
y, while 1000 mg/kg of total (i.p. and p.o.) and endocarp (i.p.) extract, i
ncreased this latency (P < 0.01, P < 0.001, respectively), which was not re
versed by naloxone (2 mg/kg). In the formalin test, SS (300 mg/kg, i.p.) an
d the extract (1000 mg/kg, p.o.) alleviated the animals nociception in the
second phase, while in the first phase they were not effective. The total a
nd endocarp extracts (1000 mg/kg, i.p.) showed a significant effect on both
phases (P < 0.01, P < 0.001, respectively) which was also not reversed by
naloxone (2 mg/kg, i.p.). In the acute anti-inflammatory test, the total ex
tract and the aqueous extract of individual fruit components showed a signi
ficant effect (P < 0.001). This anti-inflammatory effect was not significan
t compared with the anti-inflammatory effect of SS. Because of the extract
effect on the tail-flick latency and both phases of the formalin test, the
site of its analgesic action is probably central, and the mechanism of anti
nociceptive action of the extract are not related to the opioid system. Our
phytochemical studies indicated that aqueous extract of E. angustifolia fr
uit contains flavonoids, terpenoids and cardiac glycosides. (C) 2000 Elsevi
er Science Ireland Ltd. All rights reserved.